NeuroPace (NPCE) Net Margin (2020 - 2026)
NeuroPace's quarterly Net Margin came in at 29.56% in Q1 2026, down 67.0% year-on-year from 89.59% in Q1 2025, and down 188.03% quarter-over-quarter from 10.26% in Q4 2025.
NeuroPace has reported Net Margin for 7 years, with the latest figure at 29.56% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 67.0% year-over-year to 29.56%; the trailing twelve-month figure through Mar 2026 stood at 21.1% (up 853.0% YoY), and the FY2025 full-year result was 20.98%, up 1336.0% from the prior year.
- Net Margin for Q1 2026 stood at 29.56%, down from 10.26% in the prior quarter.
- The five-year high for Net Margin was 10.26% in Q4 2025, with the low at 123.58% in Q2 2022.
- Average Net Margin over 5 years is 51.44%, with a median of 39.64% recorded in 2024.
- Year-over-year, Net Margin tumbled 7308 bps in 2022 and soared 6758 bps in 2023.
- Tracing NPCE's Net Margin over 5 years: stood at 86.01% in 2022, then surged by 58 bps to 35.89% in 2023, then surged by 33 bps to 24.06% in 2024, then surged by 57 bps to 10.26% in 2025, then plunged by 188 bps to 29.56% in 2026.
- The last three Net Margin figures came in at 29.56% (Q1 2026), 10.26% (Q4 2025), and 13.08% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -29.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.56% |
| Dec 31, 2025 | -10.26% |
| Sep 30, 2025 | -13.08% |
| Jun 30, 2025 | -34.72% |
| Mar 31, 2025 | -28.89% |
| Dec 31, 2024 | -24.06% |
| Sep 30, 2024 | -26.93% |
| Jun 30, 2024 | -39.64% |
| Mar 31, 2024 | -49.53% |
| Dec 31, 2023 | -35.89% |
| Sep 30, 2023 | -44.88% |
| Jun 30, 2023 | -56.00% |
| Mar 31, 2023 | -66.04% |
| Dec 31, 2022 | -86.01% |
| Sep 30, 2022 | -104.71% |
| Jun 30, 2022 | -123.58% |
| Mar 31, 2022 | -100.74% |
| Dec 31, 2021 | -97.22% |
| Sep 30, 2021 | -76.73% |
| Jun 30, 2021 | -50.50% |
| Mar 31, 2021 | -50.79% |
| Dec 31, 2020 | -45.24% |
| Sep 30, 2020 | -30.99% |
| Jun 30, 2020 | -95.01% |
| Mar 31, 2020 | -84.77% |